QQQ   445.83 (+0.05%)
AAPL   175.50 (-2.32%)
MSFT   415.23 (-0.06%)
META   501.50 (-0.16%)
GOOGL   133.61 (-2.57%)
AMZN   178.33 (+0.06%)
TSLA   189.08 (-6.69%)
NVDA   872.91 (+6.09%)
NIO   5.36 (-7.27%)
AMD   208.70 (+2.99%)
BABA   71.98 (-3.54%)
T   16.79 (-1.12%)
F   12.88 (+3.45%)
MU   97.10 (+2.05%)
CGC   3.06 (-4.67%)
GE   160.69 (+1.29%)
DIS   113.89 (+1.73%)
AMC   4.32 (-0.92%)
PFE   25.80 (-2.97%)
PYPL   59.87 (-1.11%)
XOM   104.57 (-1.20%)
QQQ   445.83 (+0.05%)
AAPL   175.50 (-2.32%)
MSFT   415.23 (-0.06%)
META   501.50 (-0.16%)
GOOGL   133.61 (-2.57%)
AMZN   178.33 (+0.06%)
TSLA   189.08 (-6.69%)
NVDA   872.91 (+6.09%)
NIO   5.36 (-7.27%)
AMD   208.70 (+2.99%)
BABA   71.98 (-3.54%)
T   16.79 (-1.12%)
F   12.88 (+3.45%)
MU   97.10 (+2.05%)
CGC   3.06 (-4.67%)
GE   160.69 (+1.29%)
DIS   113.89 (+1.73%)
AMC   4.32 (-0.92%)
PFE   25.80 (-2.97%)
PYPL   59.87 (-1.11%)
XOM   104.57 (-1.20%)
QQQ   445.83 (+0.05%)
AAPL   175.50 (-2.32%)
MSFT   415.23 (-0.06%)
META   501.50 (-0.16%)
GOOGL   133.61 (-2.57%)
AMZN   178.33 (+0.06%)
TSLA   189.08 (-6.69%)
NVDA   872.91 (+6.09%)
NIO   5.36 (-7.27%)
AMD   208.70 (+2.99%)
BABA   71.98 (-3.54%)
T   16.79 (-1.12%)
F   12.88 (+3.45%)
MU   97.10 (+2.05%)
CGC   3.06 (-4.67%)
GE   160.69 (+1.29%)
DIS   113.89 (+1.73%)
AMC   4.32 (-0.92%)
PFE   25.80 (-2.97%)
PYPL   59.87 (-1.11%)
XOM   104.57 (-1.20%)
QQQ   445.83 (+0.05%)
AAPL   175.50 (-2.32%)
MSFT   415.23 (-0.06%)
META   501.50 (-0.16%)
GOOGL   133.61 (-2.57%)
AMZN   178.33 (+0.06%)
TSLA   189.08 (-6.69%)
NVDA   872.91 (+6.09%)
NIO   5.36 (-7.27%)
AMD   208.70 (+2.99%)
BABA   71.98 (-3.54%)
T   16.79 (-1.12%)
F   12.88 (+3.45%)
MU   97.10 (+2.05%)
CGC   3.06 (-4.67%)
GE   160.69 (+1.29%)
DIS   113.89 (+1.73%)
AMC   4.32 (-0.92%)
PFE   25.80 (-2.97%)
PYPL   59.87 (-1.11%)
XOM   104.57 (-1.20%)
NASDAQ:APM

Aptorum Group (APM) Stock Price, News & Analysis

$1.54
-0.07 (-4.06%)
(As of 02:06 PM ET)
Today's Range
$1.54
$1.59
50-Day Range
$1.39
$2.55
52-Week Range
$1.35
$9.00
Volume
1,274 shs
Average Volume
5,709 shs
Market Capitalization
$5.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

APM stock logo

About Aptorum Group Stock (NASDAQ:APM)

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.

APM Stock Price History

APM Stock News Headlines

Aptorum Group Ltd Class A (APM)
Aptorum Group Cl A Share Chat
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Aptorum Group GAAP EPS of -$1.43, revenue of $0.43M
Aptorum Group Ltd Class A APM
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
APM - Aptorum Group Limited
See More Headlines
Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/04/2024
Next Earnings (Estimated)
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APM
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.30 million
Book Value
$2.19 per share

Miscellaneous

Free Float
1,286,000
Market Cap
$5.66 million
Optionable
Not Optionable
Beta
0.10
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Chung Yuen Huen (Age 44)
    Founder, CEO & Non-Executive Director
    Comp: $923.66k
  • Mr. Martin Siu (Age 45)
    Head of Finance
    Comp: $87.34k














APM Stock Analysis - Frequently Asked Questions

How have APM shares performed in 2024?

Aptorum Group's stock was trading at $2.45 at the beginning of 2024. Since then, APM shares have decreased by 37.1% and is now trading at $1.54.
View the best growth stocks for 2024 here
.

When is Aptorum Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024.
View our APM earnings forecast
.

When did Aptorum Group's stock split?

Shares of Aptorum Group reverse split on the morning of Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Aptorum Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aptorum Group investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), Micron Technology (MU), Aridis Pharmaceuticals (ARDS).

How do I buy shares of Aptorum Group?

Shares of APM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:APM) was last updated on 3/4/2024 by MarketBeat.com Staff